City

Buffalo (1)

Houston (1)

Overall Status

Completed (2)

Withdrawn (1)

Phase

phase 1 (2)

early phase 1 (1)

Sponsor

Roswell Park Cancer Institute (2)

Baylor College of Medicine (1)

Collaborator

Cleveland BioLabs, Inc. (2)

National Cancer Institute (NCI) (1)

Intervention

entolimod (3)

laboratory biomarker analysis (2)

pharmacological study (2)

cisplatin (1)

intensity-modulated radiation therapy (1)

td vaccine (1)

Study Documents

Intervention Type

drug (3)

other (2)

biological (1)

radiation (1)

Funder Type

Other (3)

Study Type

Interventional (3)

entolimod

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Solid Tumor Trial in Buffalo (entolimod, pharmacological study, laboratory biomarker analysis)

Completed

Unspecified Adult Solid Tumor, Protocol Specific

entolimod
+2 more

Buffalo, New York

Roswell Park Cancer Institute

Jul 20, 2022

Substance Use Disorders Trial in Houston (Entolimod, Td Vaccine)

Completed

Substance Use Disorders

Entolimod
Td Vaccine

Houston, Texas

Baylor College of Medicine

Aug 28, 2020

Mucositis, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx Trial (drug,

Withdrawn

Mucositis
+37 more

entolimod
+4 more

(no location specified)

Dec 10, 2013